January 02, 2026

NK-1 Drug Fills Motion Sickness Gap

Tradipitant demonstrates 50% to 70% risk reduction for vomiting incidence during motion exposure in phase 3 trials.

Conexiant

December 09, 2025

Top 10 States to Practice Otolaryngology

From big payouts to low competition, these 10 states deliver the best mix of earnings, demand, and lifestyle for ENT specialists looking to plant roots—and practice with fewer headaches.

Conexiant

August 27, 2025

Drug for Dizziness May Increase Falls

Researchers find elevated risk across adult age groups, not just in older adults.

Conexiant

September 12, 2025

What Links GERD to Hearing and Balance Issues?

GERD links to tinnitus and balance disorders, while Barrett’s esophagus shows no ties.

Conexiant

September 30, 2025

Early Treatment Key in Sudden Deafness?

Treatment within 7 days improved hearing in sudden deafness, while adjunct therapies offered limited benefit.

Conexiant

August 05, 2025

Whole-Spine Manual Therapy for Cervical Vertigo Studied

Researchers are evaluating the impact of whole-spine manual therapy on vertigo severity, quality of life, and vertebrobasilar artery blood flow in adults with cervical vertigo.

Conexiant

September 04, 2025

Cisplatin-Free Toripalimab Tested for Head and Neck Cancer

Researchers note reduced rates of vomiting, fatigue, anemia, and leukopenia compared with standard therapy.

Conexiant

November 18, 2025

Why Do Some Struggle to Hear in Noise?

Researchers examine how lower intellectual ability is linked to poorer multitalker speech perception in neurodivergent individuals with normal hearing. 

Conexiant

June 18, 2025

Is Pediatric Vitiligo Associated With Hearing, Retinal Risks?

Pediatric vitiligo was linked to higher risks of sensorineural and mixed hearing loss, with a short-term elevated risk of certain retinal abnormalities, according to a large US-based cohort analysis.

Conexiant